ArticleOncogene2025

Induction of IL6/STAT3-dependent TRAIL expression that contributes to the therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells.

You-Take Oh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.